Ligand Pharmaceuticals
LGND
#4109
Rank
A$3.44 B
Marketcap
$182.22
Share price
2.27%
Change (1 day)
99.57%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2024 (TTM): A$84.91 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.13 Billion. In 2023 the company made an earning of A$98.32 Million a decrease over its 2022 earnings that were of A$0.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$84.91 M-13.64%
2023 A$98.32 M-7.59%
2022 A$0.10 B4%
2021 A$0.10 B296.42%
2020 A$25.8 M-97.97%
2019 A$1.27 B275.62%
2018 A$0.33 B237.48%
2017 A$0.10 B49.05%
2016 A$67.35 M55.41%
2015 A$43.33 M36.87%
2014 A$31.66 M29.59%
2013 A$24.43 M1309.35%
2012 A$1.73 M-43.97%
2011 A$3.09 M-113.19%
2010 -A$23.46 Million59.86%
2009 -A$14.68 Million-61.33%
2008 -A$37.95 Million-58.75%
2007 -A$92 Million20.52%
2006 -A$76.34 Million81.27%
2005 -A$42.12 Million
2003 -A$29.32 Million-20.6%
2002 -A$36.93 Million4.38%
2001 -A$35.38 Million-48.83%
2000 -A$69.13 Million-19.74%
1999 -A$86.13 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$46.94 Million-5.83%
1996 -A$49.84 Million136.23%
1995 -A$21.1 Million-33.97%
1994 -A$31.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.15 B 8,477.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$94.61 Million-213.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.37 B 7,545.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$25.21 B 30,128.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.86 Billion-2,321.77%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.51 B 18,507.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.52 Billion-12,712.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.12 Billion-237.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.12 B 33,620.74%๐Ÿ‡บ๐Ÿ‡ธ USA